List view / Grid view
Gene Therapy is the introduction of normal genes into cells in place of missing or defective ones in order to correct genetic disorders.
5 January 2016 | By Victoria White
Renova and Research Development Foundation (RDF) have entered into a worldwide exclusive license agreement for RDF's portfolio of urocortin and stresscopin genes, as well as select peptides and proteins...
9 December 2015 | By Victoria White
The gene therapy pipeline has more than 900 products in development, and the early-stage pipeline looks particularly strong with 76% of products at either the discovery or preclinical stage...
9 December 2015 | By Victoria White
Researchers at University of Florida have used gene therapy in a rat model to show that the expression of a particular receptor can reinstate lost memory function...
8 December 2015 | By Victoria White
Doctors are harnessing patients’ own immune systems in a pioneering trial taking place in London in an effort to find a new effective treatment for resistant head and neck cancer...
Knowledge about cancer biomarkers has increased tremendously and provides clinicians and researchers with valued opportunities to understand the molecular mechanism of cancer, thus applying it to effective, early-stage diagnosis and treatment. Cancer biomarkers include a vast range of biochemical molecules such as nucleic acids, proteins, sugars, lipids, small metabolites, cytogenetic…
1 December 2015 | By Victoria White
With Universal Cells’ proprietary gene editing technology, Adaptimmune intends to develop affinity enhanced donor T-cells...
24 November 2015 | By Kate Douetil
UCL has announced the formation of Athena Vision, a biopharmaceutical company focused on developing gene therapies for eye diseases...
16 November 2015 | By Victoria White
Scientists have reported an improved gene therapy treatment can cure mice with cystic fibrosis. Cell cultures also responded well to the treatment...
12 November 2015 | By Victoria White
The studies will evaluate the utilisation of NR2F6 gene silencing as a means of stimulating the immune system in cancer patients...
10 November 2015 | By Victoria White
In a 72-hour experiment, the inactive bacteria were able to reduce the growth of colon tumour cells by 74%...
6 November 2015 | By Victoria White
The absence of pejvakin appears to be responsible for noise-induced hearing loss, one of the most common causes of deafness...
6 November 2015 | By Victoria White
Scientists have discovered that small changes in anti-amyloid antibodies preserves the immunotherapeutic activity without the inflammatory side effects...
3 November 2015 | By Victoria White
The collaboration will leverage the scientific expertise of the two organisations to discover and develop up to five cancer immunotherapies...
26 October 2015 | By Victoria White
The US 9,181,527 Celyad Allogeneic Patent significantly strengthens Celyad’s patent portfolio in the CAR T-Cell field...
14 October 2015 | By Victoria White
Research has shown that gene therapy preserved vision in a study involving dogs with naturally occurring, late-stage retinitis pigmentosa...
